|
Professional
Experience
| 2005- present |
Reserach
Assistant Professor, University of South Carolina School of
Medicine |
| 2004 |
Instructor,
Coulter Dept. of Biomedical Engineering, Emory University
School of Medicine |
| 2000-03
|
Postdoctoral
Fellow, Division of Cardiology, Emory University School
of Medicine, Atlanta, GA |
| 1988-95
|
Research
Assistant/Teaching Assistant, Dept. of Chemical Engineering,
MIT, Cambridge, MA |
| 1984-87
|
Staff
Scientist, Giner, Inc., Waltham, MA |
| 1984 |
Research
Assistant, Giner, Inc., Waltham, MA |
Research
Interests
Dr.
Lessner’s research interests center on vascular remodeling
and angiogenesis (new blood vessel growth) in the contexts of atherosclerosis
and tissue engineering. Vascular remodeling can be defined as any
lasting change in the diameter, thickness, or structure of a mature
blood vessel. In atherosclerosis, vascular remodeling acts as a
compensatory mechanism to preserve blood flow in the face of plaque
growth, which tends to cause stenosis or narrowing of the artery.
However, vascular remodeling in atherosclerotic arteries has been
correlated pathologically with plaque rupture, which leads to adverse
clinical events such as heart attack and stroke. I am particularly
interested in the role of matrix metalloproteinases (MMPs) in vascular
remodeling and plaque vulnerability. MMPs are a class of enzymes
which can degrade the extracellular matrix. We have shown in a mouse
model of atherosclerosis that one of these enzymes, MMP-9, is required
for vascular remodeling. Control of vascular remodeling is also
important to the field of cardiovascular tissue engineering, since,
once implanted in the body, engineered constructs are subject to
the same types of cellular interactions as native tissues.
Another
phenomenon which contributes to destabilization and rupture of atherosclerotic
lesions is plaque angiogenesis. Like tumors, atherosclerotic plaques
become hypoxic as they increase in thickness, due to oxygen transport
limitations to the central core of the lesion. Tissue hypoxia promotes
angiogenesis, or growth of new capillaries into the oxygen-starved
region. I am interested in understanding both the fundamental biology
of angiogenesis within atherosclerotic lesions as well as how angiogenesis
contributes to plaque instability, using both in vitro and in vivo
approaches.
While
angiogenesis within atherosclerotic lesions may be harmful, there
are other situations in which increasing angiogenesis would be beneficial.
For example, promoting blood vessel growth into scaffolds used in
tissue engineering is an essential strategy to ensure long-term
integration and functioning of engineered tissues. Another current
area of research in my lab involves delivery of angiogenic factors
from tissue-engineered scaffolds. Confocal microscopy and other
imaging modalities available through the Instrumentation Resource
Facility are used to assess vascularization of implanted scaffolds
in mouse models.
Professional
Memberships
American Heart Association
American Chemical Society
Sigma Xi
Honors
| 2003 |
New
Investigator Travel Award, Council on Arteriosclerosis, Thrombosis,
and Vascular Biology, American Heart Association |
| 2001-03 |
NRSA Individual
Postdoctoral Fellowship (F32), National Heart, Lung, and
Blood Institute |
| 2001 |
American
Heart Association Southeast Affiliate Postdoctoral Fellowship
(declined) |
| 2001
|
Thompson
Prize, Emory University Division of Cardiology |
| 1983 |
Graduate
Fellowship, National Science Foundation |
Recent
Publications
H.-J.
Sung, C. E. Johnson, S. M. Lessner, R. Magid, D. N. Drury, and Z.
S. Galis, “Matrix Metalloproteinase (MMP)-9 Facilitates Collagen
Remodeling and Angiogenesis for Vascular Constructs,” Tissue
Eng. (in press).
S.
M. Lessner, D. E. Martinson, and Z. S. Galis, “Compensatory
Vascular Remodeling during Atherosclerotic Lesion Growth Depends
on Matrix Metalloproteinase-9 Activity,” Arterioscl. Thromb.
Vasc. Biol., 24, 2123-2129 (2004).
S.
M. Lessner and Z. S. Galis, “Matrix Metalloproteinases and
Vascular Endothelium-Mononuclear Cell Close Encounters,” Trends
Cardiovasc. Med., 14, 105-111 (2004).
S.-H.
Kim, S. M. Lessner, Y. Sakurai, and Z. S. Galis, “Cyclophilin
A as a Novel Biphasic Mediator of Endothelial Activation and Dysfunction,”
Am. J. Pathol., 164, 1567-1574 (2004).
C.
Johnson, H.-J. Sung, S. M. Lessner, M. E. Fini, and Z. S. Galis,
“Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic
Revascularization of Ischemic Tissues. Potential Role in Capillary
Branching,” Circ. Res., 94, 262-268 (2004).
J.
J. Khatri, C. Johnson, R. Magid, S. M. Lessner, K. M. Laude, S.
I. Dikalov, D. G. Harrison, H.-J. Sung, Y. Rong, and Z. S. Galis,
“Vascular Oxidant Stress Enhances Progression and Angiogenesis
of Experimental Atheroma,” Circulation, 109, 520-525 (2004).
S.
M. Lessner, H. L. Prado, E. K. Waller, and Z. S. Galis, “Atherosclerotic
Lesions Grow Through Recruitment and Proliferation of Circulating
Monocytes in a Murine Model,” Am. J. Pathol., 160, 2145-2155
(2002).
E.
Ivan, J. Khatri, C. Johnson, R. Magid, D. Godin, S. Nandi, S. M.
Lessner, and Z. S. Galis, “Expansive Arterial Remodeling Is
Associated with Increased Neointimal Macrophage Foam Cell Content.
The Murine Model of Macrophage-rich Carotid Artery Lesions,”
Circulation, 105, 2686-2691 (2002).
S.
M. Kaska, S. Sarangapani, and J. Giner, "Oxygen Reduction on
Platinum in Borate-Buffered Saline Solutions," J. Electrochem.
Soc., 136 (1), 75-83 (1989).
Z.
S. Galis and S. M. Lessner, “Inflammation and Matrix Metalloproteinases
in Atherosclerosis,” In Vulnerable Atherosclerotic Plaque,
Virmani, R., Narula, J., Naghavi, M., Casscells, S. W., and Willerson,
J. T., eds., Atlas of Non-tumor Pathology, American Registry of
Pathology (in press).
|